Interleukin 6 and cognitive dysfunction. (Q38208255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24782046 AND SRC:MED&resulttype=core&format=json

17 March 2020

title

Interleukin 6 and cognitive dysfunction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24782046 AND SRC:MED&resulttype=core&format=json

17 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24782046 AND SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Isabel Trapero

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24782046 AND SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

1 reference

30 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24782046 AND SRC:MED&resulttype=core&format=json

17 March 2020

published in

Metabolic Brain Disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24782046 AND SRC:MED&resulttype=core&format=json

17 March 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24782046 AND SRC:MED&resulttype=core&format=json

17 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24782046 AND SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

593-608

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24782046 AND SRC:MED&resulttype=core&format=json

Inflammation and Alzheimer's disease

17 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin 6 and apolipoprotein E as predictors of acute brain dysfunction and survival in critical care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Remediating deficits of switching attention in patients with acquired brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 attenuates the development of experimental diabetes-related neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Pharmacological prevention and treatment of vascular dementia: approaches and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

The participation of interleukin-6 in the pathogenesis of alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cytokines and inflammatory proteins in alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

CSF levels of cytokines in neuro-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Neuropsychologic change after cardiac surgery: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cognitive functioning in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Inflammatory markers and physical performance in older persons: the InCHIANTI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Association between interleukin 6 gene polymorphisms and Behcet's disease in Korean people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Atypical manifestations in Brazilian patients with neuro-Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Disability in older adults: evidence regarding significance, etiology, and risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 induces skeletal muscle protein breakdown in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Physiological and pathological roles of interleukin-6 in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Screening for cognitive impairment in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Inflammatory mechanisms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Intrathecal levels of IL-6 in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

TAM receptors affect adult brain neurogenesis by negative regulation of microglial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Impaired neuroglial activation in interleukin-6 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Inflammatory mediators in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Low-dose endotoxemia and human neuropsychological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Effect of autoimmune diseases on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Relationship between interleukin-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6: a cytokine and/or a major modulator of the response to somatic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cognitive impairment in Behçet's disease patients without overt neurological involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Inflammatory Blockade Restores Adult Hippocampal Neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Chronic interleukin-6 exposure alters metabotropic glutamate receptor-activated calcium signalling in cerebellar Purkinje neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 release from the human brain during prolonged exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Neuropsychological follow-up of 12 patients with neuro-Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Inflamed moods: a review of the interactions between inflammation and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

The relationship between inflammatory markers and post stroke cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Peripheral cytokine release in Alzheimer patients: correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Distinct neuroinflammatory profile in post-mortem human Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Circulating cytokines in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Calpain-dependent neurofilament breakdown in anoxic and ischemic rat central axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cerebral neurons express interleukin-6 after transient forebrain ischemia in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cerebral pattern of pro- and anti-inflammatory cytokines in dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

21 January 2018

Brain IL-6 and autism

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Intracerebroventricular injection of interleukin-1 stimulates the release of high levels of interleukin-6 and interleukin-1 receptor antagonist into peripheral blood in the primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

The metabolic syndrome, inflammation, and risk of cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-014-9551-2

Proinflammatory cytokine gene polymorphisms in Behçet's disease

21 January 2018

1 reference

12 December 2020

Interleukin-6 (IL-6) in patients with Behçet's disease

1 reference

12 December 2020

Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex

1 reference

12 December 2020

Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta

1 reference

12 December 2020

Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons.

1 reference

12 December 2020

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease

1 reference

12 December 2020

The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK

1 reference

12 December 2020

Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement

1 reference

12 December 2020

[Coping with pathological changes in nerves and blood vessels in collagen disease--CNS lupus]

1 reference

12 December 2020

Induction of interleukin-6 in axotomized sensory neurons

1 reference

12 December 2020

The -174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population

1 reference

12 December 2020

Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases

1 reference

12 December 2020

Role of cytokines in inflammatory process in Parkinson's disease.

1 reference

12 December 2020

Synergism between interleukin-6 and interleukin-1beta in hypothalamic serotonin release: a reverse in vivo microdialysis study in F344 rats

1 reference

12 December 2020

Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis

1 reference

12 December 2020

Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome

1 reference

12 December 2020

Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients

1 reference

12 December 2020

Intercellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6

1 reference

12 December 2020

On the multimeric nature of natural human interleukin-6

1 reference

12 December 2020

Study of interleukin-6 production in Alzheimer's disease.

1 reference

12 December 2020

Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement

1 reference

12 December 2020

Multiple extracellular signals are required for long-term oligodendrocyte survival

1 reference

12 December 2020

Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus

1 reference

12 December 2020

Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro

1 reference

12 December 2020

Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice

1 reference

12 December 2020

Interleukin-1β Enhances Survival and Interleukin-6 Protects against MPP Neurotoxicity in Cultures of Fetal Rat Dopaminergic Neurons

1 reference

12 December 2020

Structure of an extracellular gp130 cytokine receptor signaling complex

1 reference

12 December 2020

Refractory neuro-Behçet treated by tocilizumab: a case report

1 reference

12 December 2020

Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex

1 reference

12 December 2020

[Revised criteria for the diagnosis of Behçet's disease]

1 reference

12 December 2020

Serum levels of inflammation factors and cognitive performance in amnestic mild cognitive impairment: a Chinese clinical study

1 reference

12 December 2020

Lewy bodies and progressive dementia: a critical review and meta-analysis

1 reference

12 December 2020

Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats

1 reference

12 December 2020

Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis

1 reference

12 December 2020

Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor rece

1 reference

12 December 2020

Cytokines in Behçet's disease

1 reference

12 December 2020

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

1 reference

12 December 2020

Intracerebroventricular interleukin-6 treatment decreases body fat in rats

1 reference

12 December 2020

Neuropsychologic alterations after cardiac operation

1 reference

12 December 2020

Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

1 reference

12 December 2020

Brain hyperperfusion during cardiac operations. Cerebral blood flow measured in man by intra-arterial injection of xenon 133: evidence suggestive of intraoperative microembolism.

1 reference

12 December 2020

Long-term intellectual dysfunction following coronary artery bypass graft surgery: a six month follow-up study

1 reference

12 December 2020

3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis

1 reference

12 December 2020

Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6.

1 reference

12 December 2020

IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy

1 reference

12 December 2020

Clinicopathological study on a case of neuro-Behçet's disease: in special reference to MRI, SPECT and neuropathological findings

1 reference

12 December 2020

Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients

1 reference

12 December 2020

Tocilizumab treatment for neuro-Behcet's disease, the first report

1 reference

12 December 2020

Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells

1 reference

12 December 2020

Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?

1 reference

12 December 2020

Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Modulation of systemic interleukin-6 induction by central interleukin-1

1 reference

12 December 2020

Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy

1 reference

12 December 2020

Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures

1 reference

12 December 2020

Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain

1 reference

12 December 2020

Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.

1 reference

12 December 2020

Cognitive function in systemic lupus erythematosus: Results of a 5‐year prospective study

1 reference

12 December 2020

Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline

1 reference

12 December 2020

Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome

1 reference

12 December 2020

Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats

1 reference

12 December 2020

Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations

1 reference

12 December 2020

Neuropsychological dysfunction following elective cardiac operation. II. A six-month reassessment.

1 reference

12 December 2020

Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus

1 reference

12 December 2020

Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain

1 reference

12 December 2020